Thirty-six of 188 high-risk CHD cases (19.1%) were initially not recognized by standard prenatal or postnatal screening methods; 31 of these (86.1%) were identified as high-risk by combined NT-proBNP and IL-1 RL1 testing. This evidence concerns the gene NPPB and coronary artery disorder.